Legal Opinion
Enzo Biochem, Inc. v. Gen-Probe Inc.
Court of Appeals for the Federal Circuit
Decided September 30, 2005No. 20-1579PublishedCited by 59 opinions
1Opinion of the Court
LOURIE, Circuit Judge.
Enzo Biochem, Inc. (“Enzo”) appeals from the summary judgment of the United States District Court for the Southern District of New York holding that United States Patent 4,900,659 is invalid under the on-sale bar of 35 U.S.C. § 102(b). Enzo Biochem, Inc. v. Gen-Probe, Inc., No. 99 Civ. 3548 (S.D.N.Y. July 27, 2004) (“Order”)- Because the invention claimed in the ’659 patent was the subject of an offer for sale before the critical date, we conclude that the patent is invalid and we affirm the district court’s judgment.
BACKGROUND
Enzo is the assignee of the ’659 patent,…
2Cases cited12 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Pfaff v. Wells Electronics, Inc.Supreme Court of the United States · 1998
- Wms Gaming Inc. v. International Game TechnologyCourt of Appeals for the Federal Circuit · 1999
- Helifix Limited v. Blok-Lok, Ltd. And William Scott Burns v. Helifix North America Corporation, Third Party CounterclaimCourt of Appeals for the Third Circuit · 2000
- Monon Corporation and Rosby Corporation, Plaintiffs-Cross v. Stoughton Trailers, Inc.Court of Appeals for the Federal Circuit · 2001
7 more not listed; retrieve them via the Exa API.
3Cited by59 opinions
- Amgen Inc. v. F. Hoffmann-La Roche Ltd.Court of Appeals for the Federal Circuit · 2009
- Taurus IP, LLC v. Daimlerchrysler Corp.Court of Appeals for the Federal Circuit · 2013
- Wasica Finance GmbH v. Continental Automotive Systems, Inc.Court of Appeals for the Federal Circuit · 2017
- Zheng Cai v. Diamond Hong, Inc.Court of Appeals for the Federal Circuit · 2018
- Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2017
54 more not listed; retrieve them via the Exa API.